Author

Shuihong Yao

Observed name: S. Yao

Institution: Quzhou College of Technology

Observed institutions: Quzhou College of Technology, CStone Pharmaceuticals (China)

ORCID: 0000-0001-8963-2263

Observed ORCID: 0000-0001-8963-2263

OpenAlex ID: A5064668770

The role of RANBP1 in regulating MiRNA expression and apoptosis in breast cancer cells

2025 · Pengxia Song, Lin Zhang, et al. · Genes & Genomics · 3

RANBP1 promotes immune evasion in triple-negative breast cancer by suppressing T cell infiltration via the miR-769-5p/PRUNE2 axis

2025 · Pengxia Song, Xianglin Liu, et al. · Discover Oncology · 2

389P Updated efficacy and safety of pralsetinib in Chinese patients with advanced RET fusion+ non-small cell lung cancer

2022 · Q. Zhou, Y-L. Wu, et al. · Annals of Oncology · 2

JICC01.14 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy

2021 · Q. Zhou, Y. Wu, et al. · Journal of Thoracic Oncology · 1

SNHG6 Promotes Lipid Metabolic Reprogramming in Hepatocellular Carcinoma via Upregulation of SCD

2026 · Xin Zheng, Jiajun Lu, et al. · Journal of Hepatocellular Carcinoma

Analysis of drug resistance, virulence phenotype, and genetic sequences in microevolutionary strains of Pseudomonas aeruginosa MPAO1

2026 · Lingli Zhang, Huiping Qiu, et al. · Electronic Journal of Biotechnology

Works count: 6

Citation count: 8

H-index: 2

I10-index: